Archives: Seminars

Communicating the harms of nicotine to kids has been a core strategy to prevent youth uptake of vaping.  Jennifer Pearson will guide a discussion on the challenges public health professionals face when communicating the harms of vaping to youth in the real world. From government health messaging to working with kids in schools, this session… Read more »

The priority remains to prevent teens from becoming part of the tobacco risk continuum but what should be done for kids that are already addicted? This session will explore:  FDA’s understanding of the mindset of susceptible teens What factors contribute to making them so vulnerable For addicted teens, why FDA encourages complete cessation while still… Read more »

Comprehensive tobacco control approaches, the continuum of risk, and chronic care models of treatment for tobacco dependence are all considered important foundational elements of a public health approach to tobacco control. However, how e-cigarettes fit within each of these elements and blend these “pillars” together, as well as across the full developmental life cycle of… Read more »

Has the US lost sight of the harm continuum, are we following the science Can the US still implement a comprehensive tobacco control plan? Is dual use a failure of public health, the product or both? Is the current strategy either protecting children or helping adults, is anyone happy?

Cigarette smokers not planning to quit are often overlooked in population studies. This session will examine the methods and findings from a cohort study of 1600 adult daily cigarette smokers who did not initially use e-cigarettes and had no plans to ever quit smoking.  The main outcomes were discontinuation of cigarette smoking (i.e., no cigarette… Read more »

The most recent Cochrane evidence on the effectiveness and safety of e-cigarettes for quitting smoking Findings from new analyses of longer term e-cigarette use, the role of flavours in cessation, and biomarkers of harm How we conceptualise, communicate, and address uncertainties in the evidence base

The close links between smoking and social disadvantage and poor mental health were traditionally considered to be primarily due to smoking having a stronger appeal for people whose lives are more stressful, but with the rise of vaping, claims increased that the association shows adverse effects of nicotine on the developing brain, either during pregnancy,… Read more »

The continuum of risk is a cornerstone of a nicotine-based framework for public health proposed by the FDA in 2016. The idea is that products that deliver nicotine fall on a spectrum of risk based on toxicity and addictiveness. Combusted tobacco products such as cigarettes pose the highest risk, both in toxicity and addictiveness. An… Read more »